Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.9K Sell
1,612
-3,767
-70% -$128K ﹤0.01% 5726
2026
Q1
$140K Buy
5,379
+1,079
+25% +$45.8K ﹤0.01% 4921
2025
Q4
$156K Sell
4,300
-1,790
-29% -$73.3K ﹤0.01% 5200
2025
Q3
$301K Buy
6,090
+450
+8% +$18.3K ﹤0.01% 4683
2025
Q2
$178K Hold
5,640
– – ﹤0.01% 4835
2025
Q1
$101K Buy
5,640
+140
+3% +$3.5K ﹤0.01% 5097
2024
Q4
$189K Sell
5,500
-1,691
-24% -$44.1K ﹤0.01% 4834
2024
Q3
$160K Buy
7,191
+1,000
+16% +$16.4K ﹤0.01% 4728
2024
Q2
$86.3K Hold
6,191
– – ﹤0.01% 5015
2024
Q1
$92.3K Hold
6,191
– – ﹤0.01% 4939
2023
Q4
$57.3K Hold
6,191
– – ﹤0.01% 5217
2023
Q3
$60.5K Buy
+6,191
New +$49.1K ﹤0.01% 5079

Other funds holding IPX

Wells Fargo's IPX Position: Q2 2026 in Review

Wells Fargo reduced its IperionX (IPX) stake by 70% in Q2 2026, selling an estimated $128K and leaving 1,612 shares worth $47.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5726.

Wells Fargo first reported a position in IPX in Q3 2023 and has held it in 12 quarters since. The position peaked at $301K in Q3 2025. 58 funds tracked by Wall St. Rank hold IPX as of Q2 2026.

  • Wells Fargo held 1,612 shares of IperionX worth $47.9K as of Q2 2026.
  • Wells Fargo sold 3,767 IperionX shares in Q2 2026, an estimated $128K.
  • IperionX made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5726 holding.
  • Wells Fargo first reported a position in IperionX in Q3 2023 and has held it in 12 quarters since.
  • Wells Fargo's IperionX position peaked at $301K in Q3 2025.
  • 58 funds tracked by Wall St. Rank held IperionX as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.